Overview
Erin Ezzell is a Hematologist Oncology specialist and a Hematologist in Norman, Oklahoma. Dr. Ezzell is rated as an Experienced provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, and Paget Disease of the Breast. Dr. Ezzell is currently accepting new patients.
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
901 N Porter Ave, Norman, OK 73071
900 Ne 10th St, Ouhp Family Medicine, Oklahoma City, OK 73104
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ou Health Partners Inc
Kristin Thorp is a Hematologist Oncology specialist and a Hematologist in Norman, Oklahoma. Dr. Thorp is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Paget Disease of the Breast, Pleuropulmonary Blastoma, Colorectal Cancer, Lung Cancer, and Endoscopy. Dr. Thorp is currently accepting new patients.
Mercy Clinic Oklahoma Communities
Ashtami Banavali is a Hematologist Oncology specialist and a Hematologist in Ada, Oklahoma. Dr. Banavali is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Non-Hodgkin Lymphoma, and Lung Cancer. Dr. Banavali is currently accepting new patients.
Ou Health Partners Inc
Shari Jones is a Hematologist Oncology specialist and a Hematologist in Norman, Oklahoma. Dr. Jones is rated as an Advanced provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Breast Cancer in Men, and Small Lymphocytic Lymphoma (SLL). Dr. Jones is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Ezzell isAdvanced. Learn about Breast Cancer.
- Lung CancerDr. Ezzell isAdvanced. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Ezzell isAdvanced. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Ezzell isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Ezzell isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Ezzell isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Ezzell isExperienced. Learn about Anal Cancer.
- Angioimmunoblastic T-cell LymphomaDr. Ezzell isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- AngiosarcomaDr. Ezzell isExperienced. Learn about Angiosarcoma.
- Antiphospholipid SyndromeDr. Ezzell isExperienced. Learn about Antiphospholipid Syndrome.